These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26030244)

  • 1. Neuroendocrine tumors of the luminal gastrointestinal tract.
    Grin A; Streutker CJ
    Arch Pathol Lab Med; 2015 Jun; 139(6):750-6. PubMed ID: 26030244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
    Kim JY; Hong SM
    Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
    Lawrence B; Gustafsson BI; Kidd M; Pavel M; Svejda B; Modlin IM
    Endocrinol Metab Clin North Am; 2011 Mar; 40(1):111-34, viii. PubMed ID: 21349414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators.
    Ardill JE; O'Dorisio TM
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors.
    Stevenson R; Libutti SK; Saif MW
    JOP; 2013 Mar; 14(2):155-7. PubMed ID: 23474561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and Management of Gastrointestinal Neuroendocrine Neoplasms.
    Gonzalez RS
    Surg Pathol Clin; 2020 Sep; 13(3):377-397. PubMed ID: 32773190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathology reporting of neuroendocrine tumors: essential elements for accurate diagnosis, classification, and staging.
    Klimstra DS
    Semin Oncol; 2013 Feb; 40(1):23-36. PubMed ID: 23391110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preface: Gastroenteropancreatic system and its tumors: Part 1.
    Vinik AI
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):xvii-xviii. PubMed ID: 21095538
    [No Abstract]   [Full Text] [Related]  

  • 9. [Neoplasms of the disseminated neuroendocrine cell system of the gastrointestinal tract].
    Klöppel G
    Pathologe; 2015 May; 36(3):237-45. PubMed ID: 25947223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis of neuroendocrine tumours in the gastrointestinal tract].
    Rehfeld JF; Friis-Hansen L; Gøtze JP; Hilsted L; Nielsen FC
    Ugeskr Laeger; 2010 Oct; 172(43):2957-60. PubMed ID: 21040675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foreword: Gastroenteropancreatic system and its tumors: Part 1.
    LeRoith D
    Endocrinol Metab Clin North Am; 2010 Dec; 39(4):xiii-xvi. PubMed ID: 21095537
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of Phosphohistone H3 Cutoff Values Corresponding to Original WHO Grades but Distinguishable in Well-Differentiated Gastrointestinal Neuroendocrine Tumors.
    Kim MJ; Kwon MJ; Kang HS; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Park HC
    Biomed Res Int; 2018; 2018():1013640. PubMed ID: 29780816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary leiomyosarcomas of the gastrointestinal tract in the post-gastrointestinal stromal tumor era.
    Aggarwal G; Sharma S; Zheng M; Reid MD; Crosby JH; Chamberlain SM; Nayak-Kapoor A; Lee JR
    Ann Diagn Pathol; 2012 Dec; 16(6):532-40. PubMed ID: 22917807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerosing Tumors of the Gastrointestinal Tract: A Systematic Approach.
    Chelliah A; Kalimuthu SN; Chetty R
    Int J Surg Pathol; 2019 Aug; 27(5):468-476. PubMed ID: 30955389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical validation of the gastrointestinal NET grading system: Ki67 index criteria of the WHO 2010 classification is appropriate to predict metastasis or recurrence.
    Yamaguchi T; Fujimori T; Tomita S; Ichikawa K; Mitomi H; Ohno K; Shida Y; Kato H
    Diagn Pathol; 2013 Apr; 8():65. PubMed ID: 23607525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Presentation and Diagnosis of Neuroendocrine Tumors.
    Vinik AI; Chaya C
    Hematol Oncol Clin North Am; 2016 Feb; 30(1):21-48. PubMed ID: 26614367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers and molecular imaging in gastroenteropancreatic neuroendocrine tumors.
    Lindholm DP; Oberg K
    Horm Metab Res; 2011 Nov; 43(12):832-7. PubMed ID: 22009449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
    Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
    Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract.
    Rorstad O
    J Surg Oncol; 2005 Mar; 89(3):151-60. PubMed ID: 15719376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathological implications in the neuroendocrine gastrointestinal system].
    Piette C; Polus M; Louis E
    Rev Med Liege; 2002 Aug; 57(8):509-18. PubMed ID: 12405024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.